#Senate bill would speed #FDA OK of life saving therapies; Congress could override FDA rejections when warranted ow.ly/W1Eff
3
#Alzheimers Association thrilled as congress commits $350M to Alzheimers research in 2016 budget ow.ly/W1FAk #ENDALZ
#NIST steps up role in industry #cybersecurity; Framework user comments solicited, April 2016 workshop set ow.ly/W1E2L
JAMA report: industry research sponsorship up as #NIH funding declined since 2006; commercial interest bias feared ow.ly/W1Flb
Cancer survivor brings focus to pharma’s #patient-centric approach to #clinicalresearch; an #SSRO will fill this gap ow.ly/W1DJy
US minorities not well represented in #clinicaltrials; serious implications for #patientsafety ow.ly/W1F65
#FDA, #Pacira settle out of court, avoiding another #free-speech ruling; will not limit surgical site for pain med ow.ly/W1EEV
#PCSK9 inhibitors show slow market penetration, declining scripts; payer negotiations thought responsible ow.ly/VYnfD
#FDA advisory committee rejects proposal to add #ezetimibe to #statins for coronary heart disease standard therapy ow.ly/VYn5P
Pancreatic #fat increased in #diabetes; removal of as little as 1 gram can reverse the disease ow.ly/VYo0K #T2DM
Rapid rise in obese clients overwhelms #nursing home resources; staff, equipment and knowledge need updating ow.ly/VYmNJ
Global #diet getting sweeter; developing countries ramping up consumption to approach others ow.ly/VYnNI
Interactive brain tour from Alz.org shows regional functions and the effects of #Alzheimers ow.ly/VYnvB #ENDALZ
#Quintiles #Clinical Development President, Paula Stafford, leaving after 30 years of service ow.ly/VU4WY
Congratulations @IsisPharmaceuticals as #ALS #antisense therapy launches in #Biogen phase I/II trial ow.ly/VU3WJ
